Skip to main content

and
  1. Article

    Open Access

    Assessing the effectiveness of Interleukin-2 therapy in experimental type 1 diabetes

    Much focus of immunotherapy for type 1 diabetes (T1D) has been devoted on selectively boosting regulatory T (Treg) cells using low dose IL-2 due to their constitutive expression of IL-2Rα, CD25. However, sever...

    Zhengkang Luo, Mariela Mejia-Cordova, Nour Hamze, Elin Berggren, Saloni Chopra in Endocrine (2024)